drugset / Trial / NCT02392546

Elobixibat Colonic Motor Function Study

NCT02392546

Phase 2 Withdrawn Ferring Pharmaceuticals
RandomizedParallel-groupDouble-blindBasic science

Summary

This is a randomized trial of 36 otherwise healthy patients with chronic idiopathic constipation. The purpose of the study is to compare the effects of daily single-dose oral elobixibat and placebo for 7 days on colonic motor effects.

Timeline

Start
2015-04
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Elobixibat Small molecule 10 mg Oral
Subject Elobixibat Small molecule 15 mg Oral
Subject Elobixibat Small molecule 20 mg Oral

Indications